Treatment of previously treated subjects having colorectal cancer using an Anti-EGFR rechallenge treatment with a bispecific antibody that binds EGFR and cmet
TW202639598APending Publication Date: 2026-10-01MERUS NV +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114149190
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-16
- Filing Date
- 2025-12-15
- Publication Date
- 2026-10-01
Smart Images
Figure TWG2TA001078807_001 
Figure TWG2TA001078807_002 
Figure TWG2TA001078807_003
Abstract
The disclosure relates to means and methods in the treatment of a subject having a colorectal cancer. The disclosure in particular relates to therapeutic uses and methods involving a bispecific antibody that binds EGFR and cMET. Such bispecific antibody is particularly useful in the treatment of metastatic colorectal cancer or a locally advanced, unresectable colorectal cancer. The disclosure further relates to uses in such methods and to the use in the manufacture of a medicament for the treatment of such cancers.
Need to check novelty before this filing date? Find Prior Art